EX-23.3 3 g06286a2exv23w3.htm EX-23.3 CONSENT OF MORGAN JOSEPH & CO. INC.

Ex-23.3

Exhibit 23.3

MORGAN JOSEPH

July 6, 2007

Cumberland Pharmaceuticals, Inc.
2525 West End Avenue, Suite 950
Nashville, TN 37203

To Whom It May Concern:

      We hereby consent to the use of our name in the section of Cumberland Pharmaceuticals, Inc.’s Registration Statement entitled “Stock-Based Compensation” with respect to the undersigned having assisted management in December 2006 in the preparation of a valuation analysis for the review of Cumberland’s Board of Directors.

Regards,

/s/ Roger T. Briggs, Jr.

Roger T. Briggs, Jr.
Vice Chairman